Zobrazeno 1 - 10
of 173
pro vyhledávání: '"R. Van Damme-Lombaerts"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nicholas J. A. Webb, Alan R. Watson, David V. Milford, Karel Vondrak, Jeno Járay, Chantal Loirat, Richard S. Trompeter, R. Van Damme-Lombaerts, M. Brown, M. Fitzpatrick, Eytan Mor, Heather Maxwell, Pierre Cochat, Luisa Murer, Burkhard Tönshoff, Ryszard Grenda
Publikováno v:
American Journal of Transplantation. 10:828-836
Minimizing steroid exposure in pediatric renal transplant recipients can improve linear growth and reduce metabolic disorders. This randomized multicenter study investigated the impact of early steroid withdrawal on mean change in height standard dev
Autor:
Richard N. Fine, R. Van Damme-Lombaerts, Anneloes Decorte, S. De Geest, Todd M. Ruppar, Fabienne Dobbels
Publikováno v:
Pediatric Transplantation. 14:603-613
As most prior reviews on NA focus on adult transplant patients, there is a need for a comprehensive overview on adherence to the immunosuppressive regimen in pediatric kidney transplant patients. This systematic review searched for English-language p
Publikováno v:
Pediatric Transplantation. 5:452-456
From an experimental procedure, intestinal transplantation (ITx) has evolved over the last 10 yr into a treatment option for patients suffering from short bowel syndrome and who develop life-threatening complications from total parenteral nutrition (
Autor:
R. Van Damme-Lombaerts, Jacques Pirenne, W. Coosemans, Guy Bogaert, Diethard Monbaliu, K. Cosyns
Publikováno v:
Pediatric Transplantation. 14:E46-E48
Kidney transplantation has become the treatment of choice for children with end-stage renal disease and offers recipients an excellent quality of life. Following kidney transplantation several types of medical and surgical complications can arise. In
Publikováno v:
Pediatric Transplantation. 4:6-11
Forty-eight pediatric cadaveric renal transplantations, performed between May 1986 and February 1997, were retrospectively screened, pre- and post-transplant, for antibodies to human leukocyte antigen (anti-HLA) using complement-dependent cytotoxicit
Publikováno v:
Pediatric Transplantation. 3:282-287
Neoral is a new microemulsion formulation of cyclosporin A (CsA) that has been reported to have better absorption characteristics than sandimmune. We converted 25 long-term pediatric renal transplant recipients with a mean age of 14.1 yr and a mean f
Autor:
Jean Herman, R. Van Damme-Lombaerts
Publikováno v:
Pediatric Nephrology. 13:148-152
Erythropoietin (EPO) treatment dramatically changes the life of a child with end-stage renal disease. The administration of recombinant human (rHu)EPO is beneficial and safe in the predialysis period, during hemodialysis or peritoneal dialysis, and a
Autor:
J P Guignard, Michel Fischbach, Chantal Loirat, François Bouissou, R. Van Damme-Lombaerts, Jean-Luc André, Albert Bensman, Michel Foulard, Pierre Cochat, J M Nguyen, Hubert Nivet, Françoise Janssen, Claude Guyot
Publikováno v:
Pediatric Nephrology. 10:723-727
To determine the risk factors predictive of graft loss from chronic rejection in pediatric renal allograft recipients, we reviewed the collaborative study database of the Société de Néphrologie Pédiatrique which registered 314 grafts from January
Publikováno v:
Transplant International. 9:546-550
To study the long-term effect of cyclosporin A (CyA), 94 6-h and 29 12-h pharmacokinetic profiles were evaluated in 32 children at least 1 year after renal transplantation. Children weighing less than 25 kg needed significantly higher doses of CyA th